Houlihan Lokey, Inc.
NYSE:HLIFinancial - Capital Markets
-$1.78 today
- Market cap
- $9.66B
- Beta
- 0.95
- P/E (TTM)
- 22.0
- EPS (TTM)
- $6.42
- Dividend yield
- 1.77%
Volume 0.57M
Average 0.67M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Houlihan Lokey, Inc.
NYSE:HLI
Intrinsic Alpha fair value
Locked
Current Price
$139.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +18.3% | +15.7% (3yr)1 analysts |
| Revenue | N/A | N/A | +13.1% | +9.0% (3yr)5 analysts |
| Net Income | N/A | N/A | +18.7% | +13.6% (3yr)5 analysts |
| EBIT | N/A | N/A | +21.9% | +10.5% (3yr)5 analysts |
Analysis
Recent growth has been strongest in EBIT at +21.9% over three years. Forward estimates point to EPS at +15.7% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Morgan Stanley NYSE:MS | $300.71B | $190.65 | Overvalued | 19.5 | +12.85% |
The Goldman Sachs Group, Inc. NYSE:GS | $264.37B | $916.56 | Overvalued | 18.5 | +12.73% |
UBS Group AG NYSE:UBS | $147.91B | $48.31 | Not rated | 20.2 | +22.58% |
Evercore Inc. NYSE:EVR | $11.26B | $296.35 | Overvalued | 19.1 | -4.38% |
Stifel Financial Corp. NYSE:SF | $10.86B | $72.75 | Undervalued | 8.6 | -9.58% |
Jefferies Financial Group Inc. NYSE:JEF | $8.64B | $45.69 | Overvalued | 18.0 | -21.41% |
Piper Sandler Companies NYSE:PIPR | $4.65B | $66.23 | Overvalued | 19.7 | -18.08% |
Moelis & Company NYSE:MC | $4.14B | $56.00 | Overvalued | 22.2 | -9.25% |
Lazard Ltd NYSE:LAZ | $3.95B | $40.40 | Undervalued | 15.7 | -14.35% |
PJT Partners Inc. NYSE:PJT | $3.81B | $150.90 | Undervalued | 21.6 | -9.68% |
Continue the stock analysis
Jump to another research area for this company.